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The possibility that psychological response within a few weeks of a breast cancer diagnosis can inﬂuence the outcome of the dis-
ease is a contentious issue. Psychological response, including helplessness/hopelessness, ﬁghting spirit and depression was assessed in
early-stage breast cancer patients between 1 and 3 months post-diagnosis, in order to ascertain eﬀect on cancer prognosis. Patients
were followed up for a period of 10 years in order to clarify the eﬀect of psychological response on disease outcome. After 10 years,
there is a continuing eﬀect of helplessness/hopelessness on disease-free survival (adjusted hazard ratio (HR) 1.53, 95% conﬁdence
interval (CI) 1.11–2.11) but not of depression (adjusted HR for overall survival for cases 2.43, 95% CI 0.97–6.10). Longer fol-
low-up also indicates that a high ﬁghting spirit confers no survival advantage. The results showed that, in patients who were
disease-free at 5 years, their baseline helpless/hopeless response still exerted a signiﬁcant eﬀect on disease-free survival beyond
5 (and up to 10) years. The eﬀect is therefore maintained for up to 10 years of follow-up. Clinicians may wish to screen for
helplessness around the time of diagnosis in order to target psychological care resources. Further large studies, with similarly
prolonged follow-up, are needed to replicate this eﬀect and clarify its mechanism of action.
 2005 Elsevier Ltd. All rights reserved.
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The debate about whether psychological responses to
breast cancer, such as ﬁghting spirit, a helpless/hopeless
attitude or the presence of depression are prognostic fac-
tors inﬂuencing survival is ongoing. A large population-
based study of psychological response and survival with
5 years of follow-up published previously showed an ef-
fect of helpless/hopeless responses measured between 4
and 12 weeks after primary diagnosis on disease-free
survival in patients with early-stage breast cancer [1].0959-8049/$ - see front matter  2005 Elsevier Ltd. All rights reserved.
doi:10.1016/j.ejca.2005.01.012
* Corresponding author. Tel.: +44 20 8661 3510/3009; fax: +44 20
8661 6250/3186.
E-mail addresses: maggie.watson@rmh.nhs.uk, maggie.watson@
rmh.nthames.nhs.uk (M. Watson).This eﬀect remained signiﬁcant (adjusted hazard ratio
(HR) 1.55, 95% conﬁdence interval (CI) 1.07–2.25) after
controlling for known prognostic factors (histo-patho-
logical grade, number of positive lymph nodes, patho-
logical tumour size, type of surgery, treatment with
radiotherapy, chemotherapy and/or endocrine therapy,
oestrogen receptor status and age). Patients with a help-
less/hopeless response are characterised by a feeling that
there is nothing they can do to help themselves and a
lack of hope for the future.
The data also suggested an increased risk of death in
those women with initial high scores for Hospital Anxi-
ety and Depression Scale (HADS) depression, an eﬀect
which was strengthened after controlling for known
prognostic factors as above (adjusted HR for cases
3.59, 95% CI 1.39–9.24). In this study, we found no
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free survival of a ﬁghting spirit response, in contrast
to the positive advantage of a high ﬁghting spirit re-
sponse at 5 and 10 years which had been reported previ-
ously in a smaller study [2,3]. One consequence of such
ﬁndings may be to encourage women with breast cancer
to believe that a ﬁghting spirit may improve their sur-
vival prospects. However, where patients ﬁnd it diﬃcult
to maintain a ﬁghting spirit, this may contribute to an
increased burden of a sense of responsibility should
the cancer relapse. It is therefore important to evaluate
fully the evidence so that women with breast cancer
may be properly advised. A few studies that were dis-
cussed in our previous publication [1] have attempted
to examine the question of whether psychological re-
sponse impacts on survival, but none have reported data
on very large samples using the same psychological re-
sponses as the present study.
In the light of the above, it was considered important
to clarify our previous results, taking into account the
outcome for women with relapsed disease. Deaths from
stage I and II breast cancer continue at a fairly constant
rate to at least 10 years after initial diagnosis, thus sug-
gesting that extension of follow-up to 10 years in our
original cohort would help to crystallise the earlier re-
sults. We have therefore followed up this cohort for a
further 5 years, giving 10 years of follow-up in all. We
have investigated whether an initial helpless/hopeless re-
sponse (as measured by the Mental Adjustment to Can-
cer Scale (MAC) [4]) and depression (as measured by
HADS [5]) will have a signiﬁcant impact on both overall
and disease-free survival by 10 years of follow-up, in
addition to the already reported adverse impact on dis-
ease-free survival at 5 years. We also checked for any ef-
fect of a ﬁghting spirit response by 10 years of follow-up,
in order to clarify the previous results.2. Patients and methods
All available follow-up information on the 578 pa-
tients studied previously was collected. These were all
women with early-stage (I and II) breast cancer aged
18–75 years (mean = 55 years, SD = 10.6), who pre-
sented consecutively at the Royal Marsden Hospital,
London and Sutton, UK and were aware of their diag-
nosis. They were assessed within 4–12 weeks post-
diagnosis using the MAC and HAD scales. Study design
and patient characteristics have been described fully
elsewhere [1]. For the extended follow-up, information
on relapse, death and date last seen alive was gathered
from the Royal Marsden Hospital information system,
the Thames Cancer Registry, and the Oﬃce of National
Statistics. If patients had moved, or up-to-date informa-
tion was unavailable, general practitioners were con-
tacted. Disease-free survival was deﬁned as free fromrecurrence and not dying from breast cancer. For the
analysis of overall survival all-cause mortality was used.
All available data (i.e., no censoring) were then analysed
using Cox proportional hazards regression [6] for dis-
ease-free and overall survival over the extended follow-
up period, calculating the crude HR for each individual
psychological measure and the HR adjusted for clinical
prognostic factors (histo-pathological grade, number of
positive lymph nodes, pathological tumour size, type of
surgery, treatment with radiotherapy, chemotherapy
and/or endocrine therapy, oestrogen receptor status,
and age). The signiﬁcance of each eﬀect was assessed
using the likelihood ratio test statistic. To investigate
whether the eﬀect of psychological measures varies as
follow-up increases, the analysis was repeated for overall
survival on those women who were alive at 5 years to
ﬁnd out whether, having survived for the ﬁrst 5 years,
the initial psychological response still had any signiﬁcant
impact on prognosis. And similarly for disease-free sur-
vival, the analysis was repeated in only those women
who were disease-free at 5 years.3. Results
At 10 years only one patient was lost to follow-up.
For 12 patients their relapse status was unknown at 10
years, but they were known to be relapse-free at 5 years,
and so their follow-up was censored at the 5-year time
point for the analysis of disease-free survival. Cause of
death was known for all patients who had died. Median
follow-up in those still alive at 10 years was 11.3 years
(inter-quartile range (IQR) 10.5–11.9). After 10 or more
years of follow-up, 239 (41.3%) women had relapsed
(compared with 171 relapses within ﬁrst 5 years) and
the median time to relapse was 2.7 years (IQR 1.3–
5.4). A total of 221 (38.2%) had died (135 within 5
years), of whom 184 (31.8%) had died of breast cancer.
None of the remaining non-breast cancer deaths had a
distant relapse during follow-up. For the analyses of dis-
ease-free survival, 243 (47.2%) had died from breast can-
cer or relapsed (compared with 173 by 5 years).
Therefore, after 10 years the overall status of patients
was: 307 (53.1%) alive and without relapse, 49 (8.5%)
alive with relapse and 221 (38.2%) had died.
Table 1 contains the crude and adjusted HRs for dis-
ease-free and overall survival at 10 years. After 10 years
the risk of breast cancer death or relapse in women with
high initial scores on the MAC helplessness/hopelessness
scale was increased (adjusted HR = 1.53, 95% CI 1.11–
2.11) (see Fig. 1). The statistical signiﬁcance of this eﬀect
was greater than shown in the adjusted 5-year analysis,
although the HR estimate was very similar. There was
no signiﬁcant eﬀect of HAD depression on disease-free
survival. After 10 years there was an increased risk of
death from all causes in women with high initial scores
Table 1
Results of Cox proportional hazards regression analysis of baseline psychological measures with disease-free and overall survival in 578 early breast
cancer patients after at least 10 years of follow-up
Psychological measure Disease-free survival Overall survival
Cancer deaths
or relapses/n (%)
Crude hazard
ratio (95% CI)
Adjusted hazard
ratio (95% CI)a
Deaths/n (%) Crude hazard
ratio (95% CI)
Adjusted hazard
ratio (95% CI)a
MAC: ﬁghting spirit P = 0.47 P = 0.48 P = 0.36 P = 0.48
>47 170/412 (41.3) 1.00 1.00 154/412 (37.4) 1.00 1.00
647 71/162 (43.8) 1.11 (0.84–1.46) 1.11 (0.83–1.47) 67/162 (41.4) 1.14 (0.86–1.52) 1.11 (0.83–1.49)
MAC: helplessness/hopelessness P = 0.009 P = 0.009 P = 0.06 P = 0.10
<12 194/486 (39.9) 1.00 1.00 179/486 (36.8) 1.00 1.00
P12 49/91 (53.8) 1.52 (1.11–2.08) 1.53 (1.11–2.11) 42/91 (46.2) 1.37 (0.98–1.92) 1.34 (0.95–1.89)
MAC: anxious preoccupation P = 0.64 P = 0.95 P = 0.73 P = 0.77
<26 212/507 (41.8) 1.00 1.00 196/507 (38.7) 1.00 1.00
P26 31/69 (44.9) 1.09 (0.75–1.59) 1.01 (0.69–1.49) 24/69 (34.8) 0.93 (0.61–1.42) 0.94 (0.60–1.45)
MAC: fatalism P = 0.80 P > 0.99 P = 0.30 P = 0.83
<23 215/512 (42.0) 1.00 1.00 193/512 (37.7) 1.00 1.00
P23 26/60 (43.3) 1.05 (0.70–1.58) 1.00 (0.66–1.52) 27/60 (45.0) 1.24 (0.83–1.85) 1.05 (0.69–1.58)
MAC: avoidance P = 0.96 P = 0.66 P = 0.78 P = 0.84
<4 229/544 (42.1) 1.00 1.00 208/544 (38.2) 1.00 1.00
=4 12/29 (41.4) 0.98 (0.55–1.76) 1.15 (0.61–2.15) 10/29 (34.5) 0.91 (0.48–1.72) 1.07 (0.54–2.13)
HAD: anxiety P = 0.81 P = 0.83 P = 0.75 P = 0.46
0–7 169/407 (41.5) 1.00 1.00 154/407 (37.8) 1.00 1.00
8–10 42/102 (41.2) 1.01 (0.72–1.42) 1.05 (0.74–1.49) 39/102 (38.2) 1.05 (0.74–1.50) 1.19 (0.83–1.70)
P11 31/68 (45.6) 1.13 (0.77–1.66) 1.12 (0.76–1.67) 28/68 (41.2) 1.16 (0.78–1.74) 1.23 (0.81–1.87)
HAD: depression P = 0.45 P = 0.29 P = 0.37 P = 0.09
0–7 229/541 (42.3) 1.00 1.00 208/541 (38.4) 1.00 1.00
8–10 9/27 (33.3) 0.73 (0.37–1.42) 0.70 (0.36–1.39) 8/27 (29.6) 0.72 (0.36–1.47) 0.69 (0.34–1.40)
P11 5/10 (50.0) 1.45 (0.60–3.52) 1.74 (0.70–4.33) 5/10 (50.0) 1.61 (0.66–3.92) 2.43 (0.97–6.10)
Data were missing on the psychological measures for some patients: ﬁghting spirit (4 missing), helplessness/hopelessness (1), anxious preoccupation
(2), fatalism (6), avoidance (5), anxiety (1).
a Adjusted for histo-pathological grade, number of positive lymph nodes, pathological tumour size, type of surgery, treatment with radiotherapy,
chemotherapy and/or endocrine therapy, oestrogen receptor status, and age.
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tically signiﬁcant. The eﬀect of HAD depression on
overall survival was weaker at 10 years (adjusted HRYears since prim
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Fig. 1. Disease-free survival byfor cases = 2.43, 95% CI 0.97–6.10) than in the 5-year
analysis (adjusted HR for cases = 3.59, 95% CI 1.39–
9.24). In addition, the ﬁnding that there is no signiﬁcantary diagnosis
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response was maintained at 10 years.
Restricting the analysis to the follow-up period from
5 to 10 years gave very similar results from the complete
10-year analysis. As found with the analysis of the com-
plete follow-up data, the only statistically signiﬁcant ef-
fect was for helplessness/hopelessness and disease-free
survival (adjusted HR = 2.00, 95% CI 1.09–3.65). The
HR for helplessness/hopelessness and disease-free sur-
vival is consistent with the values obtained from the
0–5 years analysis (adjusted HR = 1.42, 95% CI 0.97–
2.08), and so there is no evidence that the eﬀect of help-
lessness/hopelessness varies as follow-up increases.4. Discussion
The present analysis updates the original result for a
helpless/hopeless response, showing continuing adverse
impact on long-term disease-free survival. The results
for HADS depression remain ambivalent due to small
numbers of patients scoring in the clinical range and,
if anything, the eﬀect for depression was weaker at 10
years follow-up. It also supports the ﬁnding that a high
ﬁghting spirit response confers no signiﬁcant survival
advantage beyond 5 years of follow-up. In trying to
understand the lack of eﬀect for the ﬁghting spirit re-
sponse it is important to take account of how this is
measured. The Mental Adjustment to Cancer (MAC)
scale assesses helpless/hopeless and ﬁghting spirit re-
sponses on two separate subscales. These measures while
inversely correlated (r = 0.46) are not polar opposites,
as the correlation value demonstrates. For patients it
may not be what extra beneﬁt is added to normal reac-
tions by a ﬁghting spirit, but rather what is left out for
those who are helpless. The opposite of a helpless/hope-
less response is not ﬁghting spirit but rather a lack of
helplessness and hopelessness; these are qualitatively
and quantitatively diﬀerent. The data conﬁrm that there
is no beneﬁt to survival of a ﬁghting spirit beyond 5
years post-diagnosis. This is an important result as it
may help to remove any continuing feelings of guilt or
sense of blame for breast cancer relapse from those wo-
men who worry because they cannot always maintain a
ﬁghting spirit or a positive attitude. While emotional
lability is common among breast cancer patients as a
normal reaction to their diagnosis and treatment, the
study underscores the need to assess the incidence of
helplessness and hopelessness and oﬀer appropriate psy-
chological care. While there has been no clear eﬀect of
depression upon survival, as assessed here, this is diﬃ-
cult to assess reliably with small numbers scoring in
the clinical range on the measure. The need to ascertain
symptoms of depression remains and the impact of
clinical depression on survival requires further
investigation.Although we have shown a statistically signiﬁcant ef-
fect of helplessness/hopelessness on disease-free survival,
the size of the eﬀect (adjusted HR = 1.53) suggests care
is needed in interpreting this clinically.
It could be argued that since the majority of events
occurred in the ﬁrst 5 years after diagnosis, it is not sur-
prising that the 10-year analysis produced similar re-
sults. The purpose of analysing the subset of patients
who were disease-free at 5 years was to investigate
whether the eﬀect of baseline psychological measures re-
mained after 5 years. The results showed that in patients
who were disease-free at 5 years, their baseline helpless/
hopeless response still exerted a signiﬁcant eﬀect on dis-
ease-free survival beyond 5 (and up to 10) years. The
eﬀect is therefore maintained for up to 10 years of
follow-up.
Although these data show an eﬀect of early psycho-
logical response on long-term disease-free survival and
reproduce the previously reported eﬀect for helpless-
ness/hopelessness, they in no way explain how or why
a helpless/hopeless response to cancer impacts on dis-
ease-free survival. Various possible mechanisms have
been suggested; impact on immune status [7], eﬀect on
stress hormones [8], or behavioural changes associated
with psychological response [9] that may impede eﬀec-
tive treatment (e.g., treatment stopped or delayed due
to patients inability to cope). Evidence from general
psychiatry may yield some clues concerning the latter
mechanism. The Cognitive Distortion Scale (John Bri-
ere) [10] deﬁnes helplessness as measuring the perception
of being unable to control or inﬂuence important, typi-
cally negative, aspects of ones life. He explains that indi-
viduals with high helplessness scores may be especially
likely to assume that their eﬀorts to change an unwanted
or problematic situation will be unsuccessful, sometimes
leading to passivity or avoidance in the face of challenge
or danger. Hopelessness is deﬁned as the extent to which
the respondent believes that the future is bleak and that
he or she is destined to suﬀer or fail [10]. Those with ele-
vated hopelessness scores are often characterised as pes-
simistic, and may be especially likely to avoid (or fail to
persevere in) activities that require an expectation of a
potentially positive outcome. In addition, high hopeless-
ness scores are usually suggestive of some level of
depression. This gives credence to the idea that a help-
less/hopeless response may impede eﬀective cancer
treatment.
Cognitive therapy or cognitive-behavioural therapy
often addresses feelings of hopelessness and helplessness
in a direct manner. It has been shown by Greer and col-
leagues [11] that a brief structured therapy of this nature
(adjuvant psychological therapy) developed for use with
cancer patients and previously tested within a random-
ised trial reduces helplessness/hopelessness. In this re-
spect, there may be beneﬁts of screening patients for
helplessness early in the disease trajectory and oﬀering
1714 M. Watson et al. / European Journal of Cancer 41 (2005) 1710–1714psychological therapy to those who show high levels of
helplessness and hopelessness. The question of whether
psychosocial interventions prolong cancer survival gen-
erally has been addressed by a number of researchers,
with contradictory results. While most studies show psy-
chological beneﬁt, especially for those who are anxious
or depressed, an editorial by Speigel in 2001 reported
that only 5 out of 10 published intervention trials
showed that various forms of psychotherapy prolonged
survival [12]. A later meta-analysis of 14 controlled
intervention trials [13] showed inconclusive results, and
therefore a deﬁnite conclusion about whether psychoso-
cial interventions prolong cancer survival seemed pre-
mature. Three of these studies showed a beneﬁt for
individual treatment, while six studies suggested that
group treatments were ineﬀective. More research is
therefore needed to ascertain whether there is an eﬀect
of such therapy on survival. The present data on psycho-
logical response and survival require replication inde-
pendently in other large studies, which should be
randomised (to avoid self-selection bias), focus the inter-
vention on a single diagnosis, and describe such inter-
ventions thoroughly.5. Conclusion
Having found evidence of an adverse impact on dis-
ease-free survival of a helpless/hopeless response at 10
years post-diagnosis, the aim now would be to clarify
the mechanisms of action and develop suitable therapies
in order to help improve outcomes in these women.Conﬂict of interest statement
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